Agendia, Inc.’s BluePrint was recently included in the latest version of German Gynecological Oncology Group (AGO) guidelines for chemotherapy decision making. AGO is comprised of gynecological ...

We have learned more this week about how former President Trump would govern if reelected. Wednesday in Wisconsin, he again ...

Guidelines now include both of Agendia’s genomic assays, MammaPrint ® and BluePrint ® IRVINE, Calif. & AMSTERDAM, April 11, 2024--(BUSINESS WIRE)--Agendia ®, Inc. announced today that the ...

Mayor Tyrin Truong posted a statement on his Facebook page saying that he was threatened by a council person "with a loaded ...

In a letter sent to Bogalusa Mayor Tyrin Truong, the state legislative auditor says Bogalusa is out of compliance with state audit laws. “Now they’re on the what’s called the non-compliance list,” ...

Cyted Health has appointed Betsy Hanna as president and US general manager, where she will lead the company’s expansion into ...

We acknowledge the financial support of Applied Biosystems, Agendia BV, the March of Dimes and the Juvenile Diabetes Research Foundation, which made it possible for the content to be freely available.

MammaPrint was originally developed at The Netherlands Cancer Institute in Amsterdam using the Rosetta Inpharmatics DNA microarray system (Merck and Co., NJ, USA) and then commercialized on the ...

The US Food and Drug Administration (FDA) has approved a new genetic test that could help patients with early-stage breast cancer predict their chance of relapse within 5 or 10 years, information ...

With institutional review board approval and Health Insurance Portability and Accountability Act (HIPPA) compliance, a multidisciplinary clinical and research data warehouse (RDW) expert group curated ...

IRVINE, Calif. & AMSTERDAM–(BUSINESS WIRE)–Agendia®, Inc. announced today that the company’s 80-gene molecular subtyping assay, BluePrint®, is now included in the latest version of German ...